MI
EBS icon

Markowski Investments’s Emergent Biosolutions EBS Stock Holding History

Markowski Investments’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6K Buy
+1,500
New +$12.6K ﹤0.01% 361

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Markowski Investments's EBS Position: Q2 2026 in Review

Markowski Investments opened a new position in Emergent Biosolutions (EBS) in Q2 2026: 1,500 shares worth $12.6K. The stake represents ﹤0.01% of the portfolio and ranks #361 among its holdings.

137 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Markowski Investments held 1,500 shares of Emergent Biosolutions worth $12.6K as of Q2 2026.
  • Emergent Biosolutions was a new Markowski Investments position in Q2 2026.
  • Emergent Biosolutions made up ﹤0.01% of Markowski Investments's portfolio in Q2 2026, its #361 holding.
  • 137 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Markowski Investments's 13F filing for Q2 2026, filed 13 Aug 2026.